Trastuzumab Biosimilar Proves Mettle in Two Breast Ca Trials (CME/CE)

(MedPage Today) -- Pfizer ' s biosimilar efficacious and safe for first-line treatment as a branded trastuzumab
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news